Cargando…
CYP2D6 Polymorphisms and the Safety and Gametocytocidal Activity of Single-Dose Primaquine for Plasmodium falciparum
Single-dose primaquine (PQ) clears mature gametocytes and reduces the transmission of Plasmodium falciparum after artemisinin combination therapy. Genetic variation in CYP2D6, the gene producing the drug-metabolizing enzyme cytochrome P450 2D6 (CYP2D6), influences plasma concentrations of PQ and its...
Autores principales: | Pett, Helmi, Bradley, John, Okebe, Joseph, Dicko, Alassane, Tiono, Alfred B., Gonçalves, Bronner P., Stone, Will, Chen, Ingrid, Lanke, Kjerstin, Neuvonen, Mikko, Mustaniemi, Anna-Liina, Eziefula, Alice C., Gosling, Roly, D’Alessandro, Umberto, Drakeley, Chris, Niemi, Mikko, Bousema, Teun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761544/ https://www.ncbi.nlm.nih.gov/pubmed/31383656 http://dx.doi.org/10.1128/AAC.00538-19 |
Ejemplares similares
-
CYP2D6 intermediate metabolizer status could slow down Plasmodium falciparum gametocyte clearance after single-dose primaquine
por: Pett, Helmi, et al.
Publicado: (2014) -
Mechanistic Modeling of Primaquine Pharmacokinetics, Gametocytocidal Activity, and Mosquito Infectivity
por: Chotsiri, Palang, et al.
Publicado: (2022) -
Age, Weight, and CYP2D6 Genotype Are Major Determinants of Primaquine Pharmacokinetics in African Children
por: Gonçalves, Bronner P., et al.
Publicado: (2017) -
The gametocytocidal efficacy of primaquine in malaria asymptomatic carriers treated with dihydroartemisinin-piperaquine in The Gambia (PRINOGAM): study protocol for a randomised controlled trial
por: Okebe, Joseph, et al.
Publicado: (2015) -
Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: Two open-label, randomized, safety trials
por: Bastiaens, Guido J. H., et al.
Publicado: (2018)